Bernstein Reiterates Hold on Cronos Group Inc. (CRON) as Cash-Rich Balance Sheet Stands Out

We recently published an article titled 9 High Growth Canadian Stocks to Buy. In this article, we are going to take a look at where Cronos Group Inc. (NASDAQ:CRON) stands against other high growth Canadian stocks to buy.

On January 14, a Bernstein analyst reiterated a Hold rating on Cronos Group Inc. (NASDAQ:CRON) and maintained a price target of $2.30, in line with the broader analyst consensus, which also stands at Hold with the same target. Despite the neutral outlook, Cronos continues to stand out for its exceptionally strong balance sheet, carrying no debt and holding approximately $824 million in cash, cash equivalents, and short-term investments—one of the most robust liquidity positions in the cannabis industry.

During its third-quarter 2025 earnings call, Cronos reported a record quarter, posting consolidated net revenue of $36.3 million, representing a 6% increase year over year. Performance was driven in part by the continued strength of the Spinach brand, which has become one of Canada’s leading cannabis brands with a 4.5% overall market share and particularly strong traction in the edibles and vape categories. Cronos Group Inc. (NASDAQ:CRON) also announced the completion of its Phase 2 expansion at GrowCo, a development expected to ease flower supply constraints and support additional growth momentum in 2026.

Cronos Group Inc. (NASDAQ:CRON) is a globally diversified, vertically integrated cannabis company with operations spanning four continents. The company owns and operates Canadian licensed production facilities, regulated under Health Canada’s framework for medical cannabis production.

While we acknowledge the potential of CRON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 13 Best Dividend Kings to Buy in 2026 and 14 Best Mid Cap Dividend Aristocrat Stocks to Buy Now

Disclosure: None.